SpeeDx gets FDA breakthrough designation for ResistancePlus GC molecular test
Australia-based SpeeDx has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its ResistancePlus…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Jun 19
Australia-based SpeeDx has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its ResistancePlus…
11 Jun 19
HP has introduced its next-generation Healthcare portfolio designed to strengthen the human connection among healthcare patients and clinicians.
Medical technology firm Immunicom has recruited first patient in multi-center and triple-negative breast cancer (TNBC) clinical trial of…
10 Jun 19
LabCorp announced a new companion diagnostic called therascreen PIK3CA PCR mutation analysis, which is now available through LabCorp…
Nvidia and King’s College London are building an AI platform designed to allow radiologists in the NHS hospitals…
Patient Care MonitoringDiagnostic DevicesIn vitro Diagnostic
06 Jun 19
Companion Medical, a leader in the development of advanced insulin delivery technology to improve diabetes care, and Glooko,…
06 Jun 19
QIAGEN and DiaSorin have expanded their QuantiFERON collaboration to develop an ultra-sensitive diagnostic test for Lyme disease, which…
BRAINBox Solutions announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its…
Mobidiag, a molecular diagnostics company, has partnered with Autobio Diagnostics, a China-based clinical diagnostics company, to launch the…
Myriad Genetics has released the results of its Phase III POLO study, which showed that BRACAnalysis CDx companion…